MANAGEMENT


Andrew M. Flanagan – President and Chief Executive Officer

Andrew M. Flanagan is the President and Chief Executive Officer of IMRIS and a member of the company’s Board of Directors. Andy oversees the global management of IMRIS and the success of the company’s leading intraoperative solutions. He leads a seasoned management team dedicated to creating and delivering patient-centricity, healthcare innovations that are safe, effective and proven to improve patient lives. Andy’s emphasis on customer success drives the company’s growth strategy.

Andy has an extensive and diverse leadership background having worked in senior roles for Siemens, SAP and Xerox. In addition, he founded an enterprise software company and led an early stage digital health company as the CEO. While at Siemens, Andy was the Senior Vice President of health services sales and business management within the customer solutions division of Siemens Healthcare, North America. In this role, he drove sales performance, services execution and customer satisfaction of the $1B+ Siemens healthcare software business in the United States.

Andy earned a Bachelor of Science from the University of Nevada, Management School of Business, Reno, Nev., and his Master’s in health informatics at Northwestern University, Evanston, Ill.

Robert Korn – Sr. Vice President, Global Sales and Marketing

With more than 25 years of experience in the Health Care Industry focused in medical device sales and marketing, Korn is a highly distinguished leader with a track record of successfully growing companies and market share while cultivating long-term relationships with healthcare customers and partners. He has an impressive background in developing and implementing best-in-class sales and marketing strategies for both Fortune 500 and start-up companies. Korn joins IMRIS from MRI Interventions, Inc. where he was accountable for all sales and clinical activities in the United States and successfully increased revenue and account installation base for their flagship product, a MRI guided navigation system that enables numerous clinical interventions in the cranial based neurosurgical arena. Rob earned a bachelor’s degree in Business Administration from The Ohio State University, Columbus, OH. 

Sarah Fyfe – Vice President of Talent & Culture

As Vice President of Talent and Culture, Sarah Fyfe is responsible for cultivating and building high performing teams to deliver against IMRIS’ vision and strategy. Through managing internal relations, building benchmark talent pools and fostering organizational effectiveness, her work focuses on driving a cohesive culture in which both employees and IMRIS thrive.

Across multiple industries, Sarah has a broad variety of human capital management experience including Organizational Design & Effectiveness, Recruiting, Employee Relations, Total Rewards and Learning & Development. Most recently, Sarah comes from Hallmark Cards, Inc. where she held various roles within a broad array of Human Resource disciplines.

She holds a Master’s Degree in Human Resources and Industrial Relations from the Carlson School of Management at the University of Minnesota, Minneapolis, MN, and a Bachelor’s Degree in Psychology from Santa Clara University, Santa Clara, CA.

Peter Simpson – Sr. Vice President, Research & Development

Peter is a successful R&D leader with vast experience delivering innovative products, focusing on cross-functional development and business line portfolio management processes throughout multiple industries and businesses. Peter has been in the medical device industry for over 13 years, and has held several leadership roles at benchmark organizations like Baxter, Covidien, and Philips.

Most recently, Peter held several leadership roles at Philips within the Diagnostic Imaging business units, including leading R&D for the X-ray business unit from Hamburg, Germany and the MR Advanced Clinical Solutions team in the U.S. He was also a co-founder and R&D leader for the Radiology Solutions business unit, and in his most recent assignment as Sr. Director, Diagnostic Imaging Idea-to-Market Team, Peter was responsible for improving strategic customer engagement, Diagnostic Imaging business positioning, and critical product quality improvements.

Peter earned his Bachelor’s degree in Mechanical Engineering and Product Design at Stanford University.

Christopher Monnot – Vice President of Finance/Controller

As Vice President of Finance/Controller, Christopher is essential to the future of our company and our mission.

A leader, an organizer and a visionary, Christopher helps maximize IMRIS’ efficiency and prepare us for what’s next – while establishing the stability that allows our teams to innovate boldly. His work ranges from FP&A and business development to process-improvement and supply-chain management.

While much of his role is behind-the-scenes, Christopher has a profound impact on IMRIS’ mission: to elevate the human experience. With his guidance, our investors and our partners have confidence; our company has the ability to grow and evolve; and our employees have the opportunity to elevate the human experience for the patients, surgeons and hospitals we serve.

Kristi Timmer – Vice President of Global Customer Service

Kristi brings over 20 years of operations and technical services leadership within the medical device industry and healthcare. Most recently, she worked at Allina Health, where she held a project management role, and prior to that she spent the majority of her career at ACIST Medical Systems, where she led their Global Service Operations team. Kristi will help IMRIS continue to build upon our current successes and lead us through key improvement opportunities. Kristi is an accomplished professional who brings strong leadership and industry experience to IMRIS.

 

BOARD OF DIRECTORS


Gregory Sorensen, MD

Dr. Sorensen is the Executive Chairman of the Board of Directors for IMRIS, the leader in image guided therapy solutions. As head of the board, Greg brings a deep understanding of technology, the biological basis of disease, the importance of measurable outcomes, and the environment of clinical practice. He was appointed to the board of directors in October 2015. He is a Neuroradiologist, well known in the industry for his innovative research in medical imaging and for his expertise in clinical practice.

Before joining IMRIS, Greg served as the president and CEO of Siemens Healthcare North America. Prior to Siemens, he served as Professor of Radiology and Health Sciences & Technology at Harvard Medical School; a faculty member of the Harvard-MIT Division of Health Sciences and Technology; and co-director of the A.A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital, as well as a visiting Professor of Neuroradiology at Oxford University.

Leading up to his appointment with Siemens, Greg was a practicing Neuroradiologist and active researcher with significant experience in clinical care, clinical trials, and translational research. His research and techniques are utilized by numerous centers throughout the world in phase II and III trials in cancer, stroke, and other illnesses. He holds a B.S. in biology from California Institute of Technology, Pasadena, CA, a M.S. in computer science from Brigham Young University, Provo, Utah, and a medical degree from Harvard Medical School, Boston, Mass.

Andrew M. Flanagan

Andrew M. Flanagan is the President and Chief Executive Officer of IMRIS and a member of the company’s Board of Directors. Andy oversees the global management of IMRIS and the success of the company’s leading intraoperative solutions. He leads a seasoned management team dedicated to creating and delivering patient-centricity, healthcare innovations that are safe, effective and proven to improve patient lives. Andy’s emphasis on customer success drives the company’s growth strategy.

Andy has an extensive and diverse leadership background having worked in senior roles for Siemens, SAP and Xerox. In addition, he founded an enterprise software company and led an early stage digital health company as the CEO. While at Siemens, Andy was the senior vice president of health services sales and business management within the customer solutions division of Siemens Healthcare, North America. In this role, he drove sales performance, services execution and customer satisfaction of the $1B+ Siemens healthcare software business in the United States.

Andy earned a Bachelor of Science from the University of Nevada, Management School of Business, Reno, Nev., and his Master’s in health informatics at Northwestern University, Evanston, Ill.

Steven Swanson, MD, MBA

Dr. Swanson recently retired from Medtronic, plc as Vice President and Chief Medical Officer for the Restorative Therapies Group (RTG) and is now the President and Principal Consultant for 3Pines M.D. Strategies, LLC; a boutique healthcare consulting firm specializing in physician executive leadership coaching, health system neuroscience center development, and medical device industry corporate healthcare strategies.

Dr. Swanson joined Medtronic in January 2014 as Vice President and Chief Medical Officer for the Restorative Therapies Group (RTG). Steve had direct responsibility for the Medical Affairs and Medical Safety functions in Neuromodulation and participated in the strategic planning for the senior leadership team. He also provided oversight for RTG Medical Affairs and Safety and played a role in key strategic growth initiatives including the Medtronic Neuroscience strategy as well as business development initiatives.

Prior to joining Medtronic, Dr. Swanson served as the President of the Neurosciences and Spine Clinical Service Line for Allina Health in Minneapolis, Minnesota. In that role, he provided both clinical and business oversight for all of neuroscience and spine services at Allina Health in Minneapolis, Minnesota. Along with clinical and administrative leaders, he led the development of multi-disciplinary clinical programs in Epilepsy, Neuro-oncology, Spine, and Neurovascular Care. In addition, he provided clinical project management for the new Bentson Family Foundation Neurological Intensive Care Unit at United Hospital in St. Paul and the first Nasseff Spine Center at WestHealth (Abbott Northwestern Hospital) in Plymouth, Minnesota. In 2012, Dr. Swanson was named as the first President of the John Nasseff Neuroscience Institute at Allina Health.

Dr. Swanson’s clinical practice and leadership career included a general adult neurosurgical practice with the Michigan Brain and Spine Institute in Ann Arbor, Michigan and more recently, the Mayo Clinic Health System in Eau Claire, Wisconsin. Additionally, he served in a variety of medical staff and neurosurgical specialty society leadership roles throughout his 25 year clinical career.

Dr. Swanson is a graduate of St. Olaf College with a B.A., Magna Cum Laude in Biology and Chemistry. He earned his MD degree at Mayo Medical School in Rochester, Minnesota and completed a residency in Neurological Surgery at the University of Michigan, serving as Chief Resident in 1984-1985. Recently, he completed the Healthcare MBA program at the University of St. Thomas in Minneapolis, Minnesota.

David Clark, JD

David is a Partner and General Counsel at Deerfield Management who serves as a member of the Private Transactions team. David joined Deerfield Management in 2009 with more than 30 years’ experience as a lawyer and business executive. Prior to Deerfield Management, David spent 10 years as a transactional lawyer with the Charlotte, North Carolina, firm of Robinson, Bradshaw & Hinson, where he led the firm’s pharmaceutical practice. Previously, David was with United Dominion Industries, a diversified manufacturing company where he served as a legal, corporate development, and international operations officer. David received an A.B. from Dartmouth College and a J.D. from The University of Texas at Austin.

Steve Hochberg

Steve has helped build, launch and grow innovative companies that have changed not only the healthcare industry, but the world.

Now, as a partner on the Private Transactions team at Deerfield Management, Steve is leveraging more than 2 decades of experience – to help us elevate not only the medical experience, but the human experience.

Steve’s credentials include:

  • Senior Vice Chairman of the Mount Sinai Health System, an integrated healthcare delivery system with over $5 billion in annual revenues.
  • Co-Founder and Manager of Ascent Biomedical Ventures, a leading venture capital firm focused on early-stage investment and development of biomedical companies. 
  • Graduate of the Harvard Business School.